Researcher Team

Jan Holgersson, MD, PhD


"We are paving the way for the development of mucin-based biopharmaceuticals targeting the vaccine and anti-microbials markets."

Tomas Johansson, PhD


“My primary objective is to establish the foundation for our purification strategies.”

Anki Gustafsson, PhD


”My focus is on maximizing the full biomedical potential of carbohydrates.”

Lena Strindelius, PhD


”Improving the uptake of antigens to increase the efficacy of vaccines is really challenging.”